MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 414644 | Name: Oxaflumazine Free Base

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Oxaflumazine Free Base is a Psychosedative.

Chemical Structure

Oxaflumazine Free Base
Oxaflumazine Free Base
CAS#16498-21-8 (free base)

Theoretical Analysis

MedKoo Cat#: 414644

Name: Oxaflumazine Free Base

CAS#: 16498-21-8 (free base)

Chemical Formula: C26H32F3N3O2S

Exact Mass: 507.2167

Molecular Weight: 507.62

Elemental Analysis: C, 61.52; H, 6.35; F, 11.23; N, 8.28; O, 6.30; S, 6.32

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
16498-21-8 (free base); 7450-97-7 (disuccinate)
Synonym
Oxaflumazine Free Base; SD270-31; SD-270-31; SD 270-31
IUPAC/Chemical Name
10-(3-(4-(2-m-Dioxanylethyl)-1-piperazinyl)propyl)-2-(trifluoromethyl) phenothiazine
InChi Key
GXCXYCOOYDMQOK-UHFFFAOYSA-N
InChi Code
InChI=1S/C26H32F3N3O2S/c27-26(28,29)20-7-8-24-22(19-20)32(21-5-1-2-6-23(21)35-24)11-3-10-30-13-15-31(16-14-30)12-9-25-33-17-4-18-34-25/h1-2,5-8,19,25H,3-4,9-18H2
SMILES Code
FC(C(C=C1N2CCCN3CCN(CCC4OCCCO4)CC3)=CC=C1SC5=C2C=CC=C5)(F)F
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 507.62 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Boissier JR, Gérardin A, Dumont C. Métabolisme de l'oxaflumazine [Metabolism of oxaflumazine]. Ann Pharm Fr. 1972 Dec;30(12):851-60. French. PMID: 4148298. 2: Lambert PA. L'action neuroleptique de l'oxaflumazine, en particulier dans les psychoses aiguës [Neuroleptic effect of oxaflumazine, especially in acute psychoses]. Therapeutique. 1972 May-Jun;48(5):385-90. French. PMID: 4403943. 3: Sichel JP, Poupier G. Expérimentation du disuccinate acide d'oxaflumazine sur 24 cas d'enfants psychotiques en milieu pédo-psychiatrique [Experimental study of oxaflumazine acid disuccinate in the treatment of 24 cases of psychotic children in a pedopsychiatric environment]. Rev Neuropsychiatr Infant. 1972 Mar- Apr;20(3):367-74. French. PMID: 5055026. 4: Deniker P, Ginestet D, Peron-Magnan P, Colonna L, Loo H. Etude clinique de l'oxaflumazine; sa place parmi les neuroleptiques [Clinical study of oxaflumazine; its place among the neuroleptics]. Therapie. 1971 Jan- Feb;26(1):227-33. French. PMID: 5554766. 5: Villeneuve A, Dogan K, Lachance R, Drolet A. Une étude pilote de l'oxaflumazine, une nouvelle phenothiazine pipérazinée [Pilot study on oxaflumazine, a new piperazinated phenothiazine]. Int J Clin Pharmacol. 1972 Aug;6(3):246-55. French. PMID: 4405378. 6: Boissier JR, Dumont C. Etude pharmacologique d'un nouveau dérivé neuroleptique: l'oxaflumazine [Pharmacological study of a new neuroleptic derivated drug: oxaflumazine]. Therapie. 1971 May-Jun;26(3):481-96. French. PMID: 5113801.

View History

FS-1

FS-1